NLRX1 Blocking Peptide Cat No: CBP7502 Source: Synthetic Reactivity: H, M, R Applications: BL Description: The peptide is used to block Anti-NLRX1 Antibody (#CPA7502) reactivity.
CREB3 Blocking Peptide Cat No: CBP7503 Source: Synthetic Reactivity: H, M, B Applications: BL Description: The peptide is used to block Anti-CREB3 Antibody (#CPA7503) reactivity.
Endothelin B Receptor Blocking Peptide Cat No: CBP7504 Source: Synthetic Reactivity: H, D Applications: BL Description: The peptide is used to block Anti-Endothelin B Receptor Antibody (#CPA7504) reactivity.
SPOP Blocking Peptide Cat No: CBP7505 Source: Synthetic Reactivity: H, M, B, Z Applications: BL Description: The peptide is used to block Anti-SPOP Antibody (#CPA7505) reactivity.
VPS35 Blocking Peptide Cat No: CBP7506 Source: Synthetic Reactivity: H, B Applications: BL Description: The peptide is used to block Anti-VPS35 Antibody (#CPA7506) reactivity.
Factor IX Blocking Peptide Cat No: CBP7508 Source: Synthetic Reactivity: H, M, R, B, D Applications: BL Description: The peptide is used to block Anti-Factor IX Antibody (#CPA7508) reactivity.
PENK Blocking Peptide Cat No: CBP7509 Source: Synthetic Reactivity: H Applications: BL Description: The peptide is used to block Anti-PENK Antibody (#CPA7509) reactivity.
Tachykinin Receptor 3 Blocking Peptide Cat No: CBP7510 Source: Synthetic Reactivity: H, M, R Applications: BL Description: The peptide is used to block Anti-Tachykinin Receptor 3 Antibody (#CPA7510) reactivity.
DCIR Blocking Peptide Cat No: CBP7511 Source: Synthetic Reactivity: H Applications: BL Description: The peptide is used to block Anti-DCIR Antibody (#CPA7511) reactivity.
SPFH1 Blocking Peptide Cat No: CBP7512 Source: Synthetic Reactivity: H, M, R, B, Z Applications: BL Description: The peptide is used to block Anti-SPFH1 Antibody (#CPA7512) reactivity.
Thymopoietin Blocking Peptide Cat No: CBP7513 Source: Synthetic Reactivity: H, M, R, B Applications: BL Description: The peptide is used to block Anti-Thymopoietin Antibody (#CPA7513) reactivity.
